Holen Sie sich die Stockscreener-App
2.21
2.21%
-0.05
Handel nachbörslich:
2.22
0.01
+0.45%
Pulmonx Corp Aktie (LUNG) Neueste Nachrichten
Pulmonx Corp Officer Radhakrishnan Srikanth Sells 14,245 Shares at $2.26 Each (NASDAQ: LUNG) - Kalkine Media
Pulmonx CEO French Glendon E. III Disposes of 41,882 Shares at $2.26 Each - Kalkine Media
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com South Africa
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com Australia
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com Nigeria
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares - Investing.com
Pulmonx general counsel David Lehman sells $32,393 in stock - Investing.com
Pulmonx chief science officer sells $32,192 in stock - Investing.com
Pulmonx (LUNG) CEO sells 41,882 shares to cover taxes - Stock Titan
Pulmonx (LUNG) exec sells shares to cover RSU taxes - Stock Titan
Pulmonx (LUNG) general counsel sells shares to cover RSU taxes - Stock Titan
Why is Pulmonx stock sliding today? - Investing.com
Why is Pulmonx stock sliding today? By Investing.com - Investing.com Australia
Pulmonx will take investor meetings in Boston and New York Sept. 9-10 - Stock Titan
Pulmonx Corp (NASDAQ: LUNG) Share Price, LUNG Stock News, LUNG Share Price & Updates - Kalkine
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year - MarketBeat
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Morgan Stanley (LUNG) reports 6.9% Pulmonx stake in updated ownership filing - Stock Titan
Pulmonx at Canaccord Genuity growth conference: turnaround gains pace - Investing.com
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript - The Globe and Mail
Pulmonx Corp 2026: Revenue $22.76M, EPS ($0.24) — 10-Q Summary - TradingView
Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Earnings Release: Here's Why Analysts Cut Their Pulmonx Corporation (NASDAQ:LUNG) Price Target To US$3.40 - Sahm
LUNG Looks 82.5% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Pulmonx Target of Unusually Large Options Trading (NASDAQ:LUNG) - MarketBeat
Earnings call transcript: Pulmonx tops Q2 2026 estimates, shares jump 14.4% - Investing.com
Pulmonx earnings beat by $0.04, revenue topped estimates - Investing.com
Pulmonx's Aug. 11 Boston fireside chat will be webcast live - Stock Titan
LUNG|Pulmonx Corp|Price:1.225|Chg%:+0.055 - TradingKey
Pulmonx Corp (LUNG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pulmonx Corp expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Pulmonx Reports Q1 2026 Earnings with Strategic Outlook - Intellectia AI
Pulmonx Market Sentiment - Benzinga España
Pulmonx Corp. Revenue Breakdown – MUN:4NI - TradingView
Pulmonx Corp (LUNG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pulmonx Corp (LUNG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pulmonx Corp (LUNG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pulmonx Corp (LUNG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pulmonx Corp (LUNG) Cash Flow - TradingKey
TradingKey - TradingKey
LUNG|Pulmonx Corp|Price:2.305|Chg%:+0.265 - TradingKey
Pulmonx (LUNG) Projected to Release Earnings on Wednesday - MarketBeat
Pulmonx Sets July 29 Webcast to Discuss Second-Quarter Results - Stock Titan
Pulmonx Corp (LUNG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pulmonx (NASDAQ:LUNG) Sparks Fresh Penny Stock Buzz - Kalkine Media
Pulmonx Corp highlights lung device strategy as a specialized medtech player - ad-hoc-news.de
Price to sales forward of Pulmonx Corporation – NASDAQ:LUNG - TradingView
Enterprise value to EBIT forward of Pulmonx Corporation – NASDAQ:LUNG - TradingView
Enterprise value to EBITDA forward of Pulmonx Corp. – LSX:A2P1AF - TradingView
Price to earnings forward of Pulmonx Corp. – LSX:A2P1AF - TradingView
Price to sales forward of Pulmonx Corp. – DUS:4NI - TradingView
Pulmonx Corp highlights its respiratory device portfolio as investors assess long-term growth prospe - Ad Hoc News
LUNG News | PULMONX CORP (NASDAQ:LUNG) - ChartMill
Pulmonx Corp. Actuals & Estimates (NASDAQ:LUNG) - TradingView
Pulmonx Corp (LUNG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Pulmonx Corp (LUNG) Institutional Confidence - TradingKey
Pulmonx Corp (LUNG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
0.86%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):